Login

Switch On Your HIV Smarts.

Surprising price break for newly-approved hepatitis C drug

Surprising price break for newly-approved hepatitis C drug

August 16, 2017, by

Two new hepatitis C cure drugs, Mavyret and Vosevi, have been approved by the FDA—offering a shorter course of treatment, for a lower cost. Read More

Long-acting antiretrovirals for HIV treatment and PrEP

Long-acting antiretrovirals for HIV treatment and PrEP

August 10, 2017, by

At the recent IAS 2017 conference, we got good news about the safety and efficacy of a long-acting antiretroviral injection and a drug in a new class of medications. Read More

Gay men living with HIV factor being ‘undetectable’ into decisions about sex

Gay men living with HIV factor being ‘undetectable’ into decisions about sex

August 8, 2017, by

People who are undetectable do not transmit HIV to others. Do people know this, and are they acting on it? Read More

Do you know U=U?

Do you know U=U?

July 28, 2017, by

Advocates for “Undetectable=Untransmittable” (U=U) were out, proud and visible this year at the International AIDS Conference, spreading the message that people living with HIV with undetectable viral loads do not transmit HIV to partners. Read More

What’s new with PrEP? Research & innovation at IAS 2017

What’s new with PrEP? Research & innovation at IAS 2017

July 27, 2017, by

Read more about studies of on-demand dosing, a long-acting injectable, and PrEP and STIs. Read More